Misdiagnosis of Idiopathic Mesenteric Phlebosclerosis: The Role of AI-Assisted Computed Tomography Pattern Recognition

Keywords

Idiopathic mesenteric phlebosclerosis
Artificial intelligence
Computed tomography
Diagnostic accuracy

Categories

How to Cite

1.
Fawad M. Misdiagnosis of Idiopathic Mesenteric Phlebosclerosis: The Role of AI-Assisted Computed Tomography Pattern Recognition. JPHPM. 2026;2(3):19-20. doi:10.64904/fpm2026.016

Abstract

Idiopathic mesenteric phlebosclerosis (IMP) is a rare form of chronic ischemic colitis that is frequently misdiagnosed due to its nonspecific clinical presentation and overlap with more common gastrointestinal conditions such as inflammatory bowel disease and ischemic colitis. Despite the presence of characteristic computed tomography (CT) findings, including serpiginous mesenteric venous calcifications and colonic wall thickening, delayed or incorrect diagnosis remains common, particularly in non-endemic regions and low-volume centers. This commentary builds upon a recently published case report to highlight the limitations of conventional diagnostic pathways and the downstream consequences of misdiagnosis, including inappropriate immunosuppressive therapy and delayed definitive management. We propose that artificial intelligence–assisted CT pattern recognition may serve as a valuable adjunct in the early identification of IMP by enhancing detection of subtle, disease-specific imaging patterns that may be overlooked during routine interpretation. Integration of AI-based decision support tools into radiologic workflows has the potential to improve diagnostic accuracy, reduce unnecessary interventions, and support preventive strategies by enabling earlier disease recognition. Further multicenter studies are warranted to evaluate the clinical utility and generalizability of AI-assisted imaging approaches in rare vascular gastrointestinal diseases.

References

[1] Hou, X., Zhang, Y., Li, J., & Wang, L. (2024). Extensive idiopathic mesenteric phlebosclerosis presenting as intestinal pseudo-obstruction: A case report. Annals of Medicine and Surgery, 86, 104789. https://doi.org/10.1016/j.amsu.2024.104789

[2] Hu XT, Wang D. Idiopathic mesenteric phlebosclerosis: a rare but important disease in Asian populations. Eur J Med Res. 2025 Apr 1;30(1):219. doi: 10.1186/s40001-025-02505-7. PMID: 40170103; PMCID: PMC11960031.

[3] Yao, T., Iwashita, A., Hoashi, T., Matsui, T., & Hoshino, M. (2015). Idiopathic mesenteric phlebosclerosis: A review of clinicopathologic, radiologic, and epidemiologic features. Journal of Gastroenterology, 50(4), 393–403. https://doi.org/10.1007/s00535-014-1003-4

[4] Kobayashi, M., Okamoto, K., Kawaguchi, S., & Yamamoto, K. (2017). Characteristic CT findings of idiopathic mesenteric phlebosclerosis and their diagnostic value. Abdominal Radiology, 42(8), 2111–2119. https://doi.org/10.1007/s00261-017-1096-8

[5] Markos, V., Kelly, S., Yee, L. F., & Lauwers, G. Y. (2019). Idiopathic mesenteric phlebosclerosis: Diagnostic pitfalls and clinicopathologic correlation. American Journal of Surgical Pathology, 43(3), 395–402. https://doi.org/10.1097/PAS.0000000000001206

[6] Topol, E. J. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56. https://doi.org/10.1038/s41591-018-0300-7

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2026 Journal of Public Health and Preventive Medicine